Literature DB >> 9619965

Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up.

L Zhu1, M Viitanen, Z Guo, B Winblad, L Fratiglioni.   

Abstract

We observed the decline in cognitive functioning in a community cohort of 924 persons aged > or =75 years with initially good cognition. Cognitive performance was indexed with the Mini-Mental State Examination (MMSE) on two occasions, 3 years apart. The average decline in MMSE score was 0.4 points per year. However, 23.4% of the participants lost more than 10% of their baseline MMSE scores. Women declined more rapidly than men. Baseline advanced age, lower education, and stroke predicted the greater decline in women. It appears that the relation of lower education and stroke with cognitive decline was more pronounced in men, but age did not predict cognitive decline in men. In addition, there was a correlation between systolic pressure reduction and cognitive decline in women, which was not accounted for by other factors. In summary, although the cognitive ability is generally spared longitudinally, in terms of the entire population, a considerable proportion of individuals show substantial decline that is related to several factors such as advanced age, female gender, lower education, stroke, and systolic pressure reduction.

Entities:  

Mesh:

Year:  1998        PMID: 9619965     DOI: 10.1016/s0895-4356(98)00003-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  19 in total

Review 1.  Hypertension and dementia.

Authors:  A S Rigaud; O Hanon; M L Seux; F Forette
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

2.  Is mid-life social participation associated with cognitive function at age 50? Results from the British National Child Development Study (NCDS).

Authors:  Ann Bowling; Jitka Pikhartova; Brian Dodgeon
Journal:  BMC Psychol       Date:  2016-12-02

Review 3.  Effects of hypertension and its treatment on mental function.

Authors:  M L Seux; F Forette
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

4.  Relation of Blood Pressure to Cognitive Impairment and Dementia.

Authors:  Christiane Reitz; Jose A Luchsinger
Journal:  Curr Hypertens Rev       Date:  2007-08-01

Review 5.  Models and mechanisms of vascular dementia.

Authors:  Poornima Venkat; Michael Chopp; Jieli Chen
Journal:  Exp Neurol       Date:  2015-05-15       Impact factor: 5.330

Review 6.  Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain.

Authors:  Teri A Manolio; Jean Olson; W T Longstreth
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

7.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

Authors:  B E de Galan; S Zoungas; J Chalmers; C Anderson; C Dufouil; A Pillai; M Cooper; D E Grobbee; M Hackett; P Hamet; S R Heller; L Lisheng; S MacMahon; G Mancia; B Neal; C Y Pan; A Patel; N Poulter; F Travert; M Woodward
Journal:  Diabetologia       Date:  2009-08-18       Impact factor: 10.122

Review 8.  Hypertension, cognitive decline, and dementia: an epidemiological perspective.

Authors:  Christophe Tzourio
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 9.  Risk factors for vascular dementia: hypotension as a key point.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Davide Manganaro; Cristina Vilotti; Gilberto Pizzolato
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Examining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study.

Authors:  Fiona Matthews; Riccardo Marioni; Carol Brayne
Journal:  BMC Geriatr       Date:  2012-08-13       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.